Faculty

Institution

Unit

Venue

Shyam Reddy

Professor and Director

Morehouse School of Medicine

Affiliations

Laboratory Of Tumor Immunology And Immunotherapy

MSM External Event Request Form

Morehouse School of Medicine

OB/GYN

Obstetrics & Gynecology

Shyam Reddy is currently serving as a Laboratory Of Tumor Immunology And Immunotherapy Professor and Director at Morehouse School of Medicine.

Honors

Create free account to unlock more features

Experiences

Create free account to unlock more features

Education

Create free account to unlock more features

Shyam Reddy

Morehouse School of Medicine

Professor and Director

You can click a keyword to filter the displayed items

cell biology molecular biology molecular cell biology gene expression genetics cell signaling oncogenes transcription (biology) molecular genetics genome biology transcription factors molecular and cellular biology signal transduction molecular cancer carcinogenesis nucleic acids proteome research cancer discovery cancer cells molecular physiology pathology plo biology cancer letter developmental cell cellular biochemistry molecular diagnostics cancer genetics signaling pathways angiogenesis forensic genetics heredity cytogenetics hematological malignancies hla typing cancer biology cell regulation cancer risk cancer genomics neovascularization rna processing splicing variant gene characterization cell cycle adult t-cell leukemia-lymphoma malignant blood disorders cancer disparities histocompatibility rna biology mitochondrial dynamics mitochondrial function protein function biomolecular interactions chromatin remodeling gene regulation nuclear organization chromosome biology medical genetics cancer treatment tumor suppressors cell adhesion chromosome 21 alternative splicing microtubule attachment stability retroviral transduction leukemogenic program hematologic malignancies clinical features family history multiple myeloma transfected mouse cells human hla rna transfected mouse mouse interferons hamster cells brca1b proteins elk‐1 transcriptional regulation molecular oncology human genome

Notable Scholarly Works

Notable Federal Grants

Collaborators

A Novel Molecular Mechanism Regulating Er α Activation/Repression and Degradation by Brca1/1A/1B in Breast Cancer Cells. Book Publisher International (a part of SCIENCEDOMAIN International) (2022)

oncogenesmolecular and cellular biologytumor biologycell deathcell signalingcell biologymolecular cancercarcinogenesismolecular cell biologycancer discoverycancer researchsignal transductionmolecular biologysystems biologycancer cellscancer letterbreast cancer

Smad3 is a Mediator of Tgf‐β ‐Induced Barrier Dysfunction and Hyperpermeability in Microvascular Endothelial Cells. The FASEB Journal (2022)

neovascularizationvascular biologyangiogenesismicrovascular endothelial cellsmatrix biologycell signalingblood vesselsimmunologycell biologymolecular medicineendothelial dysfunctionmolecular physiologymicrovascular dysfunctionextracellular matrix

neovascularizationadherens junctionsvascular biologyangiogenesismicrovascular endothelial cellsets-related gene activationcell signalingblood vesselscell biologycellular physiologymolecular cell biologysystems biologycell adhesion

gene expressiononcogenescardiovascular researchmolecular medicinetranscription factorsrespiratory medicinechronic obstructive pulmonary diseaselung cancercell biologyinterstitial lung diseasemolecular cancermolecular diagnosticssystems biologyhuman geneticsgenetic epidemiologyleukemiagenetics

Development of Bio‐Analytical Methodology and Physico‐Chemical Characterization of Novel Compound Red. The FASEB Journal (2018)

natural product researchgreen chemistryfood chemistrynatural productsanalytical toxicologydrug analysischemical engineeringnatural product communicationanalytical chemistrychromatographybioanalysisbioorganic chemistryclinical chemistrybioactive compoundschemistrybiochemistryphytochemical analysis

Development of Methodology for the Analysis of Novel Compound Rpm. The FASEB Journal (2018)

hazardous materialsengine researchmechanical testinganalytical toxicologychemical engineeringenvironmental chemistryengineeringindustrial engineeringanalytical chemistrychemical reaction engineeringchemical kineticsmechanical engineeringinternal combustion engine

Physico‐Chemical Characterization of Novel Compound Rmbr. The FASEB Journal (2018)

chemical scienceschemical engineeringstructural chemistrymedicinal chemistrychemistryorganic chemistrychemical structure

Abstract B33: Brca1 Ring Domain Mutations and Function-Based Tools to Predict Risk for the Development of Tnbc. Cancer Epidemiology Biomarkers & Prevention (2016)

Jingyao XuShanekkia BlackKartik AysolaYunlong QinVaishali ReddyKaran SinghJoel OkoliDerrick BeechUma KrishnamurthyGabriela OpreaValerie M. RiceE Shyam ReddyDouglas MoelleringYuchang FuVeena N. Rao

function-based toolsgeneticsdomain mutationscancer preventioncancer researchmolecular biologybiomarkersgene expressionhealth sciencesoncogenesmedicinal researchmolecular cancercancer riskcancer caregenome biologysurvival analysisdisease gene identificationcancer geneticscancer genomicsoncology

Family History of Hematologic Malignancies and Risk of Multiple Myeloma: Differences by Race and Clinical Features. Cancer Causes & Control (2015)

MaryAnn E. VanValkenburgGwendolyn I. PruittIlene K. BrillLuciano CostaMaryam EhtshamIan T. JustementRacquel D. Innis-SheltonDonna SalzmanE. Shyam P. ReddyKelly N. GodbyFady M. MikhailAndrew J. CarrollVishnu B. ReddyRalph D. SandersonLouis B. JustementPaul W. SandersElizabeth E. Brown

health policypublic healthcancer carehematologic malignanciesclinical featureshematological malignancieshematologyclinical epidemiologycancer disparitiesfamily historycancer researchcancer riskhealth sciencesoncologymultiple myelomarace

A Novel Pathway That Links Caveolin-1 Down-Regulation to Brca1 Dysfunction in Serous Epithelial Ovarian Cancer Cells. Enliven Challenges in Cancer Detection and Therapy (2014)

gynecologic oncologypathologycancer cellstumor biologycell signalingcell biologytumor suppressorsnovel pathwaybrca1 dysfunctionlinks caveolin-1 down-regulationovarian cancercancer geneticscancer biology

1
2
3
4
10 / page

Shyam Reddy

Professor and Director

Morehouse School of Medicine

Affiliations

Laboratory Of Tumor Immunology And Immunotherapy

MSM External Event Request Form

Morehouse School of Medicine

OB/GYN

Obstetrics & Gynecology

Shyam Reddy is currently serving as a Laboratory Of Tumor Immunology And Immunotherapy Professor and Director at Morehouse School of Medicine.

Honors

Create free account to unlock more features

Experiences

Create free account to unlock more features

Education

Create free account to unlock more features

Shyam Reddy

Morehouse School of Medicine

Professor and Director

You can click a keyword to filter the displayed items

Notable Scholarly Works

Notable Federal Grants

Collaborators

A Novel Molecular Mechanism Regulating Er α Activation/Repression and Degradation by Brca1/1A/1B in Breast Cancer Cells. Book Publisher International (a part of SCIENCEDOMAIN International) (2022)

Smad3 is a Mediator of Tgf‐β ‐Induced Barrier Dysfunction and Hyperpermeability in Microvascular Endothelial Cells. The FASEB Journal (2022)

Development of Bio‐Analytical Methodology and Physico‐Chemical Characterization of Novel Compound Red. The FASEB Journal (2018)

Development of Methodology for the Analysis of Novel Compound Rpm. The FASEB Journal (2018)

Physico‐Chemical Characterization of Novel Compound Rmbr. The FASEB Journal (2018)

chemical scienceschemical engineeringstructural chemistrymedicinal chemistrychemistryorganic chemistrychemical structure

Abstract B33: Brca1 Ring Domain Mutations and Function-Based Tools to Predict Risk for the Development of Tnbc. Cancer Epidemiology Biomarkers & Prevention (2016)

Jingyao XuShanekkia BlackKartik AysolaYunlong QinVaishali ReddyKaran SinghJoel OkoliDerrick BeechUma KrishnamurthyGabriela OpreaValerie M. RiceE Shyam ReddyDouglas MoelleringYuchang FuVeena N. Rao

Family History of Hematologic Malignancies and Risk of Multiple Myeloma: Differences by Race and Clinical Features. Cancer Causes & Control (2015)

A Novel Pathway That Links Caveolin-1 Down-Regulation to Brca1 Dysfunction in Serous Epithelial Ovarian Cancer Cells. Enliven Challenges in Cancer Detection and Therapy (2014)

1
2
3
4
10 / page